Protocol Commentary for the SUCCESS (Successful Recruitment and Retention in a Randomized Controlled Trial of Pregnant Participants with Opioid Use Disorder) Study
- 11 July 2025
- journal article
- Published by SAGE Publications in Substance use & addiction journal
- Vol. 46 (4) , 1040-1046
Abstract
Opioid use disorder (OUD) and resulting opioid-related overdoses are significant contributors to maternal morbidity and mortality. Yet very few clinical trials focus on evaluating the efficacy of medications for OUD among pregnant populations. Understanding challenges to the recruitment and retention of pregnant participants with OUD in clinical trials and identifying effective strategies to overcome these barriers are urgently needed to help improve outcomes. The SUCCESSful recruitment and retention in a randomized controlled trial of pregnant participants with opioid use disorder (SUCCESS) study was conceptualized and designed by researchers from the Medication treatment for Opioid use disorder in expectant Mothers (MOMs) trial (NIH NIDA NCT03918850). The objective of the SUCCESS study is to identify strategies, facilitators, and barriers to recruiting and retaining pregnant and postpartum participants with OUD in the MOMs trial. The SUCCESS study entails (1) semi-structured interviews with researchers from all 13 MOMs sites, (2) focus groups with MOMs trial participants, and (3) a modified Delphi process to develop data-driven guidance for future clinical trials. This commentary describes the motivation to conduct this study, presents our conceptual framework and critical decision points in protocol development, and describes the proposed product of this study.Keywords
Funding Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (UG1DA013714)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (UG1DA013720)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (UG1DA013732)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (UG1DA049436)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (UG1DA049444)
This publication has 32 references indexed in Scilit:
- Perceived Effect of Research on Clinical Care for Women With Opioid Use DisorderJournal of Obstetric, Gynecologic, & Neonatal Nursing, 2022
- Consensus in the delphi method: What makes a decision change?Technological Forecasting and Social Change, 2021
- Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulationsContemporary Clinical Trials, 2020
- Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trialThe Lancet Neurology, 2020
- Application challenges of the new EU Clinical Trials RegulationEuropean Journal of Clinical Pharmacology, 2017
- Rehabilitation After Immobilization for Ankle FractureJAMA, 2015
- Attrition in Drug Court Research: Examining Participant Characteristics and Recommendations for Follow-UpJournal of Forensic Social Work, 2013
- Qualitative interviewing with vulnerable populations: Individuals’ experiences of participating in suicide and self-harm based researchJournal of Affective Disorders, 2013
- Neonatal Abstinence Syndrome after Methadone or Buprenorphine ExposureNew England Journal of Medicine, 2010
- Participation and retention in drug abuse treatment services researchJournal of Substance Abuse Treatment, 2002